Skip to main content
SpringerLink
Log in

Entzündungen und Stoffwechselstörungen

SGLT2-Inhibitoren im Alter - auf was Sie achten müssen

SGLT2-inhibitors (gliflozins) - multipurpose medications and the statins of the 21st century?

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© J. Zeeh

Author information

Authors and Affiliations

  1. Geriatrische Fachklinik Georgenhaus, Meiningen, Deutschland

    Joachim Zeeh (Ehem. Chefarzt)

Authors
  1. Joachim Zeeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joachim Zeeh.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeeh, J. SGLT2-Inhibitoren im Alter - auf was Sie achten müssen. MMW - Fortschritte der Medizin 165, 46–48 (2023). https://doi.org/10.1007/s15006-023-2811-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-023-2811-5

Keywords:

Search

Navigation